{"database": "lobbying", "table": "lobbying_activities", "rows": [[1742485, "4c6e81cd-c801-4f8e-a94b-a059e3486410", "Q3", "KING & SPALDING LLP", 21632, "SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)", 2015, "third_quarter", "PHA", "Issues related to inclusion of prescription drugs within Essential Health Benefit; H.R. 2646, Helping Families in Mental Health Crisis Act of 2015; S. 1945, Mental Health Reform Act of 2015; and mental health coverage expansion", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2015-10-19T18:29:00.380000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1742485"], "units": {}, "query_ms": 3.232855990063399, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}